Advertisement

TheBody.com/TheBodyPRO.com cover the XVIII International AIDS Conference (AIDS 2010)

IAC Day 4: Malignancies and People Living With HIV/AIDS

July 21, 2010

Dr. Valdiserri at work at IAC.

Dr. Valdiserri at work at IAC.

This article was cross-posted from the AIDS.gov blog. Dr. Ron Valdiserri is Deputy Assistant Secretary for Health, Infectious Diseases at the U.S. Department of Health and Human Services.

Today at the International AIDS Conference meeting, researchers from the United States, France, Canada, and Romania presented findings on the important clinical topic of malignancies that can develop in people with HIV/AIDS. Scientists from the U.S. National Cancer Institute reported that the rates of so-called "AIDS-defining malignancies," like Kaposi's sarcoma and non-Hodkgin lymphoma (NHL), have decreased over time in the United States while the cancer burden for other malignancies, like lung cancer, Hodgkin lymphoma, and anal cancer has increased among HIV-infected Americans.

Similar findings were presented by researchers from Emory University in Atlanta, GA. They found that -- compared to the general population -- people with advanced HIV infection had higher rates of liver cancer, anal cancer, and lung cancer. In addition, in general, cancer diagnoses among people with HIV/AIDS occurred at a younger age compared to the general population.

Among men who have sex with men (MSM) who are living with HIV, anal cancer is a particular concern. French researchers reported that rates of pre-cancerous anal lesions among MSM did not improve or change as a result of successful treatment with highly active antiretroviral therapy (HAART), and that French physicians are seeing an increase in anal cancer among HIV-infected MSM -- even those on HAART.

Taken together, these findings remind us that ongoing clinical care, including regular screening for cancer and other malignancies, is a necessary component of high-quality care for those living with HIV/AIDS.

If you would like to learn more about the subject of malignancy and HIV, please visit the National Cancer Institute website.

Read more of Positive Policy, TheBody.com's multi-author blog on law, policy and activism.




This article was provided by TheBody. It is a part of the publication The XVIII International AIDS Conference.
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.